Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

131.51
Delayed Data
As of Dec 07
 -5.22 / -3.82%
Today’s Change
97.52
Today|||52-Week Range
164.04
-16.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues404.9M369.0M412.6M408.2M
 
 
 
 
 
Cost of Goods Sold17.3M700.0K12.1M15.4M
 
 
 
 
 
Depreciation And Amortization8.0M--7.9M8.2M
 
 
 
 
 
Operating ExpensesGross Income379.6M368.3M392.6M384.6M
 
 
 
 
 
General Expenses224.5M4.6M107.4M146.0M
 
 
 
 
 
Research And Development75.9M-400.0K35.2M45.9M
 
 
 
 
 
Total Operating Expenses249.8M5.3M127.4M169.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income155.1M363.7M285.2M238.6M
 
 
 
 
 
Interest Expense On Debt546.0K600.0K600.0K500.0K
 
 
 
 
 
Other Expenses1.5M800.0K1.1M1.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income156.0M363.9M285.7M239.1M
 
 
 
 
 
Income Taxes-51.4M-128.4M-79.6M-77.3M
 
 
 
 
 
Net Income104.6M235.5M206.1M161.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS45.7M45.4M44.3M43.2M
 
 
 
 
 
Shares To Calculate EPS Diluted49.7M48.7M46.9M46.2M
 
 
 
 
 
 
Earnings Per ShareEPS$2.10$4.84$4.39$3.50
 
 
 
 
 
EPS Diluted$2.10$4.84$4.39$3.50